...
首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >In vivo exposure of Swiss albino mice to chronic low dose of dimethylnitrosamine (DMN) lowers poly-ADP-Ribosylation (PAR) of bone marrow cell and blood lymphocyte proteins
【24h】

In vivo exposure of Swiss albino mice to chronic low dose of dimethylnitrosamine (DMN) lowers poly-ADP-Ribosylation (PAR) of bone marrow cell and blood lymphocyte proteins

机译:瑞士白化病小鼠体内的慢性低剂量二甲基亚硝胺(DMN)暴露可降低骨髓细胞和血液淋巴细胞蛋白的聚ADP核糖基化(PAR)

获取原文
获取原文并翻译 | 示例

摘要

Efforts to identify an easy and convenient biomarker of carcinogenesis with potentials of application in mass screening program continue. In a series of investigations on mice exposed to different carcinogens, poly-ADP-ribosylation (PAR) of cellular proteins of different tissues has been shown to be a potential biomarker of carcinogenesis. Because blood based biomarker of carcinogenesis offers significant advantage in its use in a cancer screening program, this investigation was undertaken to find correlations between initiation of carcinogenesis and PAR of bone marrow cell (BMC) and blood lymphocyte (BL) proteins in mice chronically exposed to low dose of dimethylnitrosamine (DMN) for up to four weeks in vivo. The exposure was either alone or in combination with 3-aminobenzamide (3-AB), an inhibitor of PAR. Total PAR of cellular proteins and of histone H1 protein were monitored by slot and Western blot immunoprobe assays, respectively. The PAR of total cellular proteins as well as of histone H1 was down-regulated in duration of exposure dependent manners. The results suggest that BMC and BL mirrored status of PAR in other tissues. This finding opens up the possibility of using PAR as a biomarker of carcinogenesis in a blood based test utilizing immunoprobe assay of cellular PAR.
机译:继续努力寻找一种简便易行的致癌生物​​标志物,并有望在大规模筛查计划中应用。在对暴露于不同致癌物的小鼠的一系列研究中,不同组织的细胞蛋白的聚ADP-核糖基化(PAR)已被证明是潜在的致癌生物​​标志物。由于基于血液的癌变生物标志物在癌症筛查程序中的应用具有显着优势,因此进行了这项研究,以发现长期暴露于这种疾病的小鼠中,癌变的发生与骨髓细胞(BMC)和血液淋巴细胞(BL)蛋白的PAR之间存在相关性。低剂量的二甲基亚硝胺(DMN)在体内长达4周。单独或与PAR抑制剂3-氨基苯甲酰胺(3-AB)组合暴露。细胞蛋白和组蛋白H1蛋白的总PAR分别通过狭缝和Western blot免疫探针测定法进行监测。总细胞蛋白以及组蛋白H1的PAR均以依赖于暴露的方式下调。结果表明,BMC和BL反映了其他组织中PAR的状态。这一发现开辟了在基于PAR的免疫探针测定的基于血液的测试中将PAR用作致癌生物标志物的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号